Published in Wiad Lek on January 01, 2007
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study. Lancet Neurol (2011) 3.36
Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology (2012) 2.18
Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet (2011) 2.00
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci Transl Med (2012) 1.99
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83
Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol (2010) 1.69
Middle cerebral artery vasospasm: transcranial color-coded duplex sonography versus conventional nonimaging transcranial Doppler sonography. Crit Care Med (2009) 1.53
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol (2011) 1.40
[Periprocedural and late complications after percutaneous closure of patent foramen ovale: a single centre experience]. Kardiol Pol (2012) 1.38
[Deep brain stimulation and motor cortex and spinal cord stimulation in the treatment of movement disorders and pain syndromes -- the theoretical baseline and practical guidelines]. Neurol Neurochir Pol (2006) 1.38
Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism Relat Disord (2008) 1.34
Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections. Funct Neurol (2007) 1.20
Kidneys in chronic liver diseases. World J Gastroenterol (2012) 1.10
GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. Am J Neurodegener Dis (2013) 1.03
Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension. World J Gastroenterol (2011) 1.00
Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature. Hepat Mon (2011) 0.97
Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson's disease risk in a Polish PD cohort. J Neural Transm (Vienna) (2008) 0.96
Various patterns of gestes antagonistes in cervical dystonia. Parkinsonism Relat Disord (2007) 0.96
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease. Neurobiol Aging (2009) 0.95
Polymorphism in semaphorin 5A (Sema5A) gene is not a marker of Parkinson's disease risk. Neurosci Lett (2006) 0.93
The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications. Pharmacogenet Genomics (2008) 0.92
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet (2012) 0.90
Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants. Neurobiol Aging (2013) 0.89
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One (2012) 0.88
From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up. Neurol Neurochir Pol (2009) 0.88
Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia. Arch Neurol (2007) 0.87
Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery. Pol J Pathol (2010) 0.87
Blood cadmium, mercury, and lead in children: an international comparison of cities in six European countries, and China, Ecuador, and Morocco. Environ Int (2012) 0.87
Analysis of LRRK 2 G 2019 S and I 2020 T mutations in Parkinson's disease. Neurosci Lett (2005) 0.86
Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia. J Neurol Sci (2013) 0.86
Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol (2010) 0.85
Human leukocyte antigen variation and Parkinson's disease. Parkinsonism Relat Disord (2011) 0.85
Composite neuroendocrine and adenomatous carcinoma of the papilla of Vater. World J Gastroenterol (2009) 0.85
Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population. Eur Neurol (2005) 0.85
Severe dilated cardiomyopathy as a consequence of Ecstasy intake. Cardiovasc Pathol (2007) 0.84
[Polish forum for prevention guidelines on cardiovascular risk assessment]. Kardiol Pol (2007) 0.84
Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease. J Neurol Sci (2009) 0.84
CARD15 variants in patients with sporadic Parkinson's disease. Neurosci Res (2006) 0.83
Botulinum toxin improves the quality of life and reduces the intensification of depressive symptoms in patients with blepharospasm. Parkinsonism Relat Disord (2007) 0.83
Interleukin-10 gene polymorphism in Parkinson's disease patients. Arch Med Res (2007) 0.82
Vascular risk factors and intensity of cognitive dysfunction in MCI. J Neurol Sci (2007) 0.81
Level of DNA damage in lead-exposed workers. Ann Agric Environ Med (2010) 0.81
Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int (2013) 0.81
Mitochondrial transcription factor A variants and the risk of Parkinson's disease. Neurosci Lett (2009) 0.81
Phenotype of the DYT1 mutation in the TOR1A gene in a Polish population of patients with dystonia. A preliminary report. Neurol Neurochir Pol (2008) 0.79
Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. Hepatol Int (2011) 0.79
[Assessment of apolipoprotein E genotype in Parkinson disease patients with and without dementia]. Wiad Lek (2004) 0.79
Polish Forum for Prevention Guidelines on Arterial Hypertension. Kardiol Pol (2007) 0.79
Haemobilia causing acute pancreatitis after percutaneous liver biopsy. J Hepatol (2004) 0.79
PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups. Parkinsonism Relat Disord (2012) 0.79
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium. Mov Disord (2013) 0.79
Blood selenium concentration in a selected population of children inhabiting industrial regions in Upper Silesia (Poland). Environ Toxicol Pharmacol (2012) 0.78
Association of pyridoxal kinase and Parkinson disease. Ann Neurol (2010) 0.78
[Significance of serum concentrations of pro- and anti-inflammatory cytokines in identification of patients with Crohn's disease]. Pol Merkur Lekarski (2010) 0.78
Polish forum for prevention guidelines on dyslipidaemia. Kardiol Pol (2008) 0.78
Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease. Parkinsonism Relat Disord (2008) 0.78
Omentin serum concentration and hepatic expression in chronic hepatitis C patients - together or apart? Pol J Pathol (2015) 0.77
The influence of visual control on postural stability in Parkinson disease. Neurol Neurochir Pol (2011) 0.77
Polish Forum for Prevention Guidelines on overweight and obesity. Kardiol Pol (2008) 0.77
Decompressive hemicraniectomy in ischaemic stroke. Neurol Neurochir Pol (2010) 0.77
Serum vaspin may be a good indicator of fibrosis in chronic hepatitis C and is not altered by antiviral therapy. Pol J Pathol (2012) 0.77
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease. Neurobiol Aging (2011) 0.77
Polish Forum for Prevention Guidelines on cardiovascular diseases prevention in children and adolescents. Kardiol Pol (2010) 0.77
A multicenter study on the audiometric findings of styrene-exposed workers. Int J Audiol (2011) 0.77
In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol (2013) 0.77
Comment on "Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta". J Immunol (2009) 0.77
Polish Forum for Prevention Guidelines on physical activity. Kardiol Pol (2009) 0.77
Treatment of pruritus with Prometheus dialysis and absorption system in a patient with benign recurrent intrahepatic cholestasis. Hepatol Res (2013) 0.76
Critical flicker frequency fails to disclose brain dysfunction in patients with primary biliary cirrhosis. Dig Liver Dis (2010) 0.76
Corticobasal degeneration -- clinico-pathological considerations. Folia Neuropathol (2006) 0.76
[Inferior frontal region hypoperfusion in Parkinson disease with dementia]. Neurol Neurochir Pol (2003) 0.76
Polish Forum for Prevention Guidelines on Diabetes. Kardiol Pol (2008) 0.76
Perfusion computed tomography in prediction of functional outcome in patients with acute ischaemic stroke. Nucl Med Rev Cent East Eur (2009) 0.76
Effect of occupational lead exposure on α- and γ-tocopherol concentration in plasma. Occup Environ Med (2013) 0.76
Polish forum for prevention guidelines on diet. Kardiol Pol (2008) 0.76
The effect of occupational lead exposure on blood levels of zinc, iron, copper, selenium and related proteins. Biol Trace Elem Res (2012) 0.76
Polish forum for prevention guidelines on smoking. Kardiol Pol (2008) 0.76
Age and immunoglobulin G4-associated autoimmune hepatitis. Liver Int (2009) 0.75
ALS-FTD complex disorder due to C9ORF72 gene mutation: description of first Polish family. Eur Neurol (2014) 0.75
[Stereotactic pallidotomy and thalamotomy in the treatment of primary dystonia]. Neurol Neurochir Pol (2007) 0.75
[Parkinsonism in chronic occupational metallic mercury intoxication]. Neurol Neurochir Pol (2003) 0.75
Effects of chronic exposure to lead, cadmium, and manganese mixtures on oxidative stress in rat liver and heart. Arh Hig Rada Toksikol (2015) 0.75
A composite model including visfatin, tissue polypeptide-specific antigen, hyaluronic acid, and hematological variables for the diagnosis of moderate-to-severe fibrosis in nonalcoholic fatty liver disease: a preliminary study. Pol Arch Med Wewn (2014) 0.75
[Clinical classification of tremor]. Wiad Lek (2002) 0.75
An open-label study to evaluate the safety, tolerability and efficacy of rivastigmine in patients with mild to moderate probable Alzheimer's disease in the community setting. Med Sci Monit (2002) 0.75
Percutaneous closure of the left atrial appendage to prevent ischaemic stroke in patients with atrial fibrillation who require but have contraindications to oral anticoagulation. Neurol Neurochir Pol (2012) 0.75
Acute intracranial in-stent thrombosis after angioplasty of middle cerebral artery symptomatic stenosis: a case report. Neurologist (2012) 0.75
[Serum level of TNF-alpha receptor type II better correlates with severity of Crohn's disease than other cytokines and conventional clinical activity indicators]. Pol Merkur Lekarski (2010) 0.75
[Assessment of prevalence of intrapulmonary arterio-venous shunt in cirrhotic patients qualified to liver transplantation]. Wiad Lek (2009) 0.75